BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 23, 2009
View Archived Issues
Amantadine improves tardive dyskinesia in schizophrenia patients
Read More
Cytokine starts phase I study of oral CPSI-2364, a chemically modified semapimod
Read More
LX-1032 receives EMEA orphan drug designation for carcinoid syndrome
Read More
Florpiramine F 18 displays potential utility as an imaging biomarker in AD; phase II data disclosed
Read More
Foresight reports results from a pilot study of FST-100 in viral conjunctivitis
Read More
Compugen reports effects of novel peptide in animal model of retinopathy
Read More
Phase III lubiprostone results released for opioid-induced bowel dysfunction
Read More
FDA grants approval to ViroMed for phase II clinical trial of VM-202
Read More
Histamine antagonist PF-03654746 under development as treatment for AD; phase I data presented
Read More
AZD-3480 fails to meet primary outcome in phase IIb trial in mild to moderate AD
Read More
Distinct mechanism of action of chimeric variants of the anti-TLR-2 antibody OPN-301 disclosed
Read More
CCR2-targeting fusion protein CCL2-LPM developed for the treatment of autoimmune conditions
Read More
Actelion describes novel lipoxin receptor agonists
Read More
Korea Institute of Science and Technology claims biosynthesized compounds
Read More
AVEO and OSI expand drug discovery and translational research collaboration in cancer
Read More
Amgen describes novel TRPM8 ligands for the treatment of pain and other diseases
Read More
Novel 11beta-HSD1 inhibitors claimed by Vitae Pharmaceuticals for the treatment of diabetes
Read More
Concert Pharmaceuticals patents orexin receptor antagonists for the treatment of sleep disorders
Read More
FDA approves Incyte's SPA for phase III trial of INCB-18424 in myelofibrosis
Read More
Novavax selects RSV vaccine candidate for additional preclinical studies to support IND
Read More
Poniard reports results from phase I cardiac safety study of chemotherapy agent picoplatin
Read More
FoldRx reports preliminary results from phase II/III clinical study of tafamidis
Read More
Bayer and Onyx report results from phase II trial of Nexavar and capecitabine in breast cancer
Read More
Critical Outcome Technologies initiates drug discovery program for Alzheimer's disease
Read More
Living Cell initiates phase I/IIa clinical trial of diabetes drug DiabeCell
Read More